Medicine and Dentistry
Radiation Therapy
100%
Breast Cancer
81%
Overall Survival
52%
Chemoradiotherapy
47%
Neoplasm
43%
Recurrent Disease
40%
Bile Duct Cancer
33%
Adjuvant Chemoradiotherapy
33%
Extrahepatic Bile Duct
31%
Surgery
28%
Prognostic Factor
28%
Quadrantectomy
27%
Rectum Cancer
25%
Disease Free Survival
24%
Retrospective Study
24%
Survival Rate
23%
Lymph Node
22%
Adjuvant Radiotherapy
22%
Multivariate Analysis
21%
Mastectomy
19%
Neoadjuvant Chemotherapy
16%
Distant Metastasis Free Survival
16%
Breast Radiotherapy
14%
Distant Metastasis
14%
Brain Metastasis
13%
Surgical Margin
12%
Hazard Ratio
12%
Hepatocellular Carcinoma
12%
Intensity Modulated Radiation Therapy
11%
Malignant Neoplasm
10%
Local Recurrence Free Survival
10%
Pancreas Cancer
9%
Adjuvant Therapy
9%
Lymph Node Metastasis
9%
Whole Brain Radiotherapy
9%
Cholangiocarcinoma
8%
Disease
8%
Recurrence Free Survival
8%
Pelvis
8%
Fluorouracil
7%
Systemic Therapy
7%
Adjuvant Chemotherapy
7%
Supraclavicular Lymph Node
7%
Meta-Analysis
7%
Volumetric Modulated Arc Therapy
7%
Adenocarcinoma
6%
Univariate Analysis
6%
Intraductal Carcinoma
6%
Lymph Node Irradiation
6%
Metastatic Carcinoma
6%
Phyllodes Tumor
6%
Squamous Cell Carcinoma
6%
Carcinoembryonic Antigen
5%
Surveillance, Epidemiology, and End Results
5%
Pancreaticoduodenectomy
5%
Propensity Score Matching
5%
Conservative Treatment
5%
Progression Free Survival
5%
Cervical Cancer
5%
Gamma Urogastrone
5%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
39%
Neoplasm
37%
Breast Cancer
28%
Recurrent Disease
27%
Survival Rate
22%
Rectum Cancer
20%
Bile Duct Cancer
18%
Disease Free Survival
15%
Distant Metastasis Free Survival
12%
Fluorouracil
12%
Retrospective Study
11%
Pancreas Cancer
11%
Local Recurrence Free Survival
9%
Malignant Neoplasm
8%
Distant Metastasis
8%
Recurrence Free Survival
8%
Liver Cell Carcinoma
7%
Lymph Node Metastasis
6%
Disease
6%
Progression Free Survival
6%
Phyllodes Tumor
6%
Brain Metastasis
6%
Adenocarcinoma
5%